ECMO, the highest level of mechanical life support, functions as a temporary heart and lungs for some of COVID-19's sickest patients. But the waitlist is too long for many patients who need it.
Using the COVID vaccine "off-label" — whether that's for booster shots or young children — may be tempting to some vaccine providers, but the CDC warns it could get them into trouble.
Worries about waning immunity and talk of COVID booster shots has some Americans checking their antibody levels to see if they're protected. But scientists warn blood tests don't tell the full story.
The pandemic has made people more open to seeking help, a new survey finds, but cost and difficulty in finding a mental health care provider are still big obstacles.
After vaccination, antibody levels can help predict how much protection a COVID-19 shot offers, scientists are learning. The finding could speed up the development of future vaccines.
Starting treatment for addiction in the emergency room greatly improves the chances recovery will last, experts say. Cutting red tape, hiring advocates and Uber vouchers can all make a difference.
The lab has access to a high-security facility that Pfizer needed to prove its COVID-19 vaccine was working. Now the scientists there are testing the vaccine's effectiveness against viral variants.
Some people have reported getting a lighter or heavier period after getting a COVID-19 vaccine. Cause for concern? Doctors say no. Could it be a temporary side effect? That's harder to determine.
Alzheimer's researchers are trying new treatment approaches, including trying to boost the immune system, remove toxic tangles of protein and stimulate brain waves with light and sound.
U.S. Olympic heptathlete Annie Kunz says tracking her monthly cycles and learning she needs to eat more and get more naps when she's fatigued has already improved her athletic performance.
Weeks after the Food and Drug Administration approved the Alzheimer's drug Aduhelm, doctors are struggling to figure out who should get the drug and how to use it safely.
To get a new drug for postpartum depression, some insurers want women to try other drugs first and even electroconvulsive therapy. It could be a test for California's new mental health parity law.
Clinical trials show Wegovy triples the average weight loss seen with other drugs. Whether it will reach many patients largely depends on whether insurers decide to cover it.
Scientists successfully treated a rare disease with the experimental gene-editing technique. It could open the door to new ways of treating more common disorders in the future.
